FDA Inspection 1291838 — Children's Hospital Los Angeles

Children's Hospital Los Angeles — FEI 2016501

The FDA completed an inspection of Children's Hospital Los Angeles on September 22, 2025 in Los Angeles, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 22, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Los Angeles, CA (United States)